Navigation Links
Experimental drug lets B cells live and lymphoma cells die
Date:9/21/2009

An investigative drug deprived non-Hodgkin lymphoma cells of their ability to survive too long and multiply too fast, according to an early study published recently in the journal Experimental Hematology.

To function normally, the cells that make up bodily tissues must "decide" when to divide and multiply (proliferate) and when to die. Cell death restricts the human cell population as a counterbalance to growth, and billions of cells must die each year just to hold the number constant. Cell growth and death are carefully regulated by signaling networks, which either encourage or discourage survival. When this counterpoise mistakenly shifts too far in favor of growth, tumors result.

One such network revolves around neurotropins, which "tell" nerve cells not to die, and to keep multiplying, as part of normal function. The same neurotrophic signals are known to cause cancers of the central nervous system when unbalanced by carcinogens. The current study found that neurotrophins also cause key immune cells to resist cell death and proliferate as part of the most deadly of lymphomas, and that an experimental compound, the fungal chemical called K252a, restored their ability to die.

Non-Hodgkin Lymphoma (NHL) is the umbrella for more than 30 cancer types that develop in an important type of white blood cell, the lymphocyte. Lymphocytes include B cells, workhorses of the immune system that attach to invaders (e.g. bacteria, viruses) and produce an army of antibodies designed to attack the specific pathogen at hand. In NHL, B cells in the lymphatic system grow abnormally, and most patients are diagnosed too late to benefit from conventional chemotherapy.

"New approaches to the treatment of non-Hodgkin Lymphoma are urgently needed, and the results of this study outline one with unusual promise," said Sanjay Maggirwar, Ph.D., associate professor in the Department of Microbiology & Immunology at the University of Rochester Medic
'/>"/>

Contact: Greg Williams
Greg_Williams@urmc.rochestere.edu
585-273-1757
University of Rochester Medical Center
Source:Eurekalert

Page: 1 2 3 4

Related medicine news :

1. Experimental Treatment Could Fight Muscular Dystrophy
2. Experimental Urine Test Spots Appendicitis
3. Senetek PLC Gains Six Year Extension of Rights from Czech Republic Institute of Experimental Botany
4. Experimental drug shows promise against head and neck cancer
5. Experimental agents may prevent radiation-induced leukemia
6. Experimental insulin-like growth factor receptor inhibitor reduced pancreatic cancer growth
7. Hard to Treat Diseases (HTDS) Releases experimental results in the treatment of (MS) Multiple Sclerosis
8. Experimental Drug May Dampen Severe Asthma
9. Experimental Drug May Prevent Plaque Buildup
10. Experimental Biology 2009 meets April 18-22
11. Experimental Weight-Loss Pill Passes Early Test
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/3/2015)... ... August 03, 2015 , ... ... research organisations (CROs) for a slew of benefits, allowing them to gain access ... boost quality with cost-effective utilisation of resources, get access to innovation and ensure ...
(Date:8/3/2015)... CA (PRWEB) , ... August 03, 2015 , ... ... services to help patients in need. Most people know that general health emergencies, such ... Unfortunately, a fewer amount of people know where to turn to during a dental ...
(Date:8/3/2015)... ... August 03, 2015 , ... AxoGen, Inc. (NASDAQ: AXGN), ... scheduled to present at the Wedbush Healthcare Conference on Wednesday, August 12, 2015 at ... and subsequent archived replay of the Company’s presentation may be accessed via the investor ...
(Date:8/3/2015)... ... 2015 , ... A July 13 article from The Daily Mail titled ... Painkiller That Can Last 'For Five Weeks'" discusses the use of stem cells ... showed that harvesting stem cell-rich bone marrow from the hip, known as bone marrow ...
(Date:8/3/2015)... ... 2015 , ... Constantin Vasilica, 48 from Romania wanted to have an alternative ... many years of suffering and using medications with strong side effects. This had already ... extra time off or wait longer hours in the waiting rooms. Instead, he went ...
Breaking Medicine News(10 mins):Health News:Global CRO Market Space Reviewed by Aniruddha Sowale in In-demand Research Report Available at MarketPublishers.com 2Health News:Global CRO Market Space Reviewed by Aniruddha Sowale in In-demand Research Report Available at MarketPublishers.com 3Health News:Los Angeles Dental Practice, Sunset Plaza Dental, Now Offers Emergency Dental Services 2Health News:Los Angeles Dental Practice, Sunset Plaza Dental, Now Offers Emergency Dental Services 3Health News:AxoGen, Inc. to Present at the Wedbush Healthcare Conference 2Health News:Los Angeles Spine Surgeon Gives Insight into How Stem Cells Can Relieve Back Pain 2Health News:Los Angeles Spine Surgeon Gives Insight into How Stem Cells Can Relieve Back Pain 3Health News:Chinese Health Care Provider Heshoutang Now Give Patients Complimentary Online Healing Options 2Health News:Chinese Health Care Provider Heshoutang Now Give Patients Complimentary Online Healing Options 3
... at Moffitt Cancer Center in Tampa, Fla., have found ... patients with gastrointestinal malignancies to higher body mass index ... negative outcomes, there was no such link. They concluded ... or esophageal cancer patient survival. Their study was ...
... News) -- The common cold appears to increase the ... them more sensitive, which triggers coughing, wheezing and breathlessness, ... especially vulnerable to this virus-induced coughing, said the researchers ... known as transient receptor potential (TRP) receptors. ...
... boys rated reading more valuable as an activity after ... new study. The findings come from a study ... and who participated in a reading improvement class that ... authors, Dara Williams-Rossi, Southern Methodist University, Dallas. The ...
... What happens on the day before a colonoscopy may ... Gastroenterologists at Washington University School of Medicine in ... prep for the test by cleansing their colons, doctors ... in the journal Gastrointestinal Endoscopy , the researchers ...
... Steven Reinberg HealthDay Reporter , MONDAY, March ... a novel "monoclonal antibody" lowered LDL cholesterol levels in ... percent. This new treatment could help lower levels ... who don,t respond to the commonly prescribed cholesterol-lowering drugs ...
... By Steven Reinberg HealthDay Reporter , MONDAY, March 26 ... with chest pain aren,t having a heart attack, but it can ... a new study finds that a special kind of CT scan ... faster than traditional methods, so patients can be sent home safely ...
Cached Medicine News:Health News:Does BMI affect post-surgical complications, survival in esophageal adenocarcinoma? 2Health News:Research Shows How Colds Lead to Coughing, Wheezing 2Health News:Middle school boys who are reluctant readers value reading more after using e-readers 2Health News:Middle school boys who are reluctant readers value reading more after using e-readers 3Health News:Poor colonoscopy prep hides pre-cancerous polyps 2Health News:Poor colonoscopy prep hides pre-cancerous polyps 3Health News:Poor colonoscopy prep hides pre-cancerous polyps 4Health News:New Injection Might Lower Tough-to-Treat Cholesterol 2Health News:New Injection Might Lower Tough-to-Treat Cholesterol 3Health News:CT Scans Can Spot Heart Trouble Fast 2Health News:CT Scans Can Spot Heart Trouble Fast 3
(Date:8/3/2015)... Aug. 3, 2015  EnteroMedics Inc. (NASDAQ: ETRM ), ... treat obesity, metabolic diseases and other gastrointestinal disorders, today ... appointed to the Board of Directors, effective July 31, ... Director until the 2018 annual meeting or until her ... has served in an executive capacity in the healthcare ...
(Date:8/2/2015)... 3, 2015  Lexicon Pharmaceuticals, Inc. (Nasdaq: ... Phase 3 clinical trial met its primary endpoint, ... treating cancer patients with carcinoid syndrome that is ... care. Telotristat etiprate was discovered using Lexicon,s gene ... the company,s first discovery to complete a pivotal ...
(Date:7/31/2015)... Ill. , July 31, 2015 ... ® (NABP ® ) issued a report ... ensuring that action is taken against websites illegally ... Internet Drug Outlet Identification Program Progress Report ... , thousands of websites illegally distribute ...
Breaking Medicine Technology:EnteroMedics Announces Appointment of Lori C. McDougal to the Board of Directors 2EnteroMedics Announces Appointment of Lori C. McDougal to the Board of Directors 3Lexicon Pharmaceuticals Reports Positive Top-Line Results For Pivotal Phase 3 Telotristat Etiprate Study In Cancer Patients With Carcinoid Syndrome 2Lexicon Pharmaceuticals Reports Positive Top-Line Results For Pivotal Phase 3 Telotristat Etiprate Study In Cancer Patients With Carcinoid Syndrome 3Lexicon Pharmaceuticals Reports Positive Top-Line Results For Pivotal Phase 3 Telotristat Etiprate Study In Cancer Patients With Carcinoid Syndrome 4Lexicon Pharmaceuticals Reports Positive Top-Line Results For Pivotal Phase 3 Telotristat Etiprate Study In Cancer Patients With Carcinoid Syndrome 5Lexicon Pharmaceuticals Reports Positive Top-Line Results For Pivotal Phase 3 Telotristat Etiprate Study In Cancer Patients With Carcinoid Syndrome 6NABP Stresses Need for Accountability in Enforcing Internet Policies to Protect the Public From Illegal Online Drug Sellers 2NABP Stresses Need for Accountability in Enforcing Internet Policies to Protect the Public From Illegal Online Drug Sellers 3
... As a leader in unified RIS/PACS, Avreo continues ... for preview at RSNA.  Version 7 represents an extensive ... , All new modern design with focus ... Cross-platform support, including Windows®, Mac OS® X, Apple® ...
... Radiological Society of North America (RSNA) Annual Meeting will ... to FUJIFILM Medical Systems U.S.A., Inc.,s PACS offering from ... ® PACS 4.0 includes improvements to image visualization ... and improve overall efficiency.  The latest ...
Cached Medicine Technology:Avreo Previews Version 7 RIS/PACS at RSNA 2Fujifilm Demonstrates the Latest Advancements of Synapse® PACS at RSNA 2Fujifilm Demonstrates the Latest Advancements of Synapse® PACS at RSNA 3
... The many benefits of fibre bronchoscopy: The ... by which all other fibre bronchoscopes are ... bronchoscopes from PENTAX, including the FB-19TV, FB-18V ... slim FB-10V and the pediatric FB-8V, offer ...
... many benefits of fibre bronchoscopy: The HF-compatible ... which all other fibre bronchoscopes are measured., ... from PENTAX, including the FB-19TV, FB-18V and ... FB-10V and the pediatric FB-8V, offer much ...
... benefits of fibre bronchoscopy: The HF-compatible V ... all other fibre bronchoscopes are measured., ... PENTAX, including the FB-19TV, FB-18V and FB-15V ... and the pediatric FB-8V, offer much better ...
... fiberoptic bronchoscopes offers a ... with a slim outside ... allows for improved suction ... cytology brushes. The scope ...
Medicine Products: